PLEK2 and cancer: Further analysis using blood fractionation showed that CD45− and CD45+ populations were responsible for the altered expression levels of PLEK2 and C1QB, respectively, indicating the importance of analyzing whole blood cells for blood-based biomarker studies of cancer.